Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

46.27USD
4:04pm EDT
Price Change (% chg)

$0.73 (+1.60%)
Prev Close
$45.54
Open
$46.50
Day's High
$47.17
Day's Low
$45.20
Volume
267,731
Avg. Vol
127,436
52-wk High
$47.17
52-wk Low
$33.71

CRL.N

Chart for CRL.N

About

Charles River Laboratories International, Inc. is a global provider of solutions, which accelerate the early-stage drug discovery and development process. The focus of its business is in vivo biology; its portfolio includes research models and services required to enable in vivo drug discovery and development. The Company... (more)

Overall

Beta: 1.23
Market Cap (Mil.): $2,232.79
Shares Outstanding (Mil.): 49.03
Dividend: --
Yield (%): --

Financials

  CRL.N Industry Sector
P/E (TTM): 21.80 47.13 37.76
EPS (TTM): 2.09 -- --
ROI: 7.84 -2.58 18.76
ROE: 17.09 -2.66 19.59
Search Stocks

Charles River Labs quarterly profit beats estimates

- Contract medical researcher Charles River Laboratories International Inc reported a better-than-expected quarterly profit, following the lead of rival Covance Inc , as drug companies increasingly outsource research.

31 Jul 2013

Charles River Labs quarterly profit beats estimates

July 31 - Contract medical researcher Charles River Laboratories International Inc reported a better-than-expected quarterly profit, following the lead of rival Covance Inc, as drug companies increasingly outsource research.

31 Jul 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Stock Traders Daily
$58.00
Provider: Stock Traders Daily
$495.00
Provider: Plunkett Research, Ltd.
$99.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks